Medication: Brand Name then Brand Name and then Brand Name again!

You are probably familiar with the patent length of new drugs but in case you are not, it is 20 years. What happens when the patent expires? You think you know the answer since you see so many generics and most medical providers will only pay for generics. Even if brand name medications are covered, chances are you are out of pocket with a bigger deductible. This is what you find–particularly for older medicines–but not for those that are not so old. Why not? I hope you are sitting… if not, take a seat please!

Do you read The Economist? If not, you should. Lately, toward the end of the magazine, there are several science sections from which you can learn the latest of what is truly the driving force behind our scientific and medical status. I found the link to the article I am about to discuss, so feel free to read it. In case you have the have the paper edition; it is on page 72 in the June 21st 2014 issue. This is an amazing and very shot one-page article.

The article sums up what happens to brand name drugs after the 20-year patent and exclusivity expires. I was shocked to read the choices these pharmaceuticals make and the most interesting part is that it is all legal. When I got my doctorate, because my field is medical experimenting on human volunteers, I had to spend a couple of years studying law, specifically human rights and everything relating to patents. In fact I have a rather fiery article poking fun of one particular case that happened in the 1970 where a doctor practiced experimenting without consent, made a ton of money by selling his unauthorized collection of blood from the patient and patented it, something that exists in nature–completely against all patent laws. Although I gave a link to the book, the title of my article is not visible: Patenting Lives. Chapter 5: Forfeited Consent: Body Parts in Eminent Domain.

This particular book is out of print now for the 3rd or 4th time since it is used as a text book but is available in Kindle–mind you it is still very expensive, so forget it. But I just wanted to show you that I am familiar with the subject and have the right to poke fun again; this time over the pharmaceutical companies who get away with murder and with the patent office yet again!

So here is what is happening in short: normally patent expires in 20 years, so this means the end of being the only company selling the drug. Using the patent information, other companies can identify precisely what is in the drug and re-create it as a generic, selling it for a fraction of the cost. This means the death of the brand name of course, something Big Pharma cannot allow to happen. So they have created some options for themselves that are “legal.” And I place quotes around the word “legal” because the law states that something can only be patented if it is genuinely something new both in design and function. If one of the two does not hold, the item cannot be patented.

Yet Big Pharma found a way around this and just before the patent of a drug would expire, they create another version of the same drug with modifying something (probably a non-essential additive) and market it again as new, apply for a patent and they get it! Yet the drug is essentially the same and it certainly has the exact same function else it could not be prescribed for the same illness. Thus we have a broken patent office system that does not see past its nose–or perhaps there is some political interest involved.

Another alternative is they buy off potential generic manufacturers trying to sell generic–meaning they pay other companies who would manufacture the generic in order to not manufacture and sell generic. Although this costs money, they still earn more money then if they had let the generic drugs come to the stores. According to The Economist, in 2012 alone there were 40 such deals that cost the Big Pharma “only” 3.5 Billion but of course they earned $8.1 Billion, so the payout was pocket change.

A third trick by Big Pharma is to nudge customers (doctors in this case) toward other drugs that behave similarly. I now understand why my mother’s doctor kept on switching her from her Simvastatin cholesterol drug that worked perfectly well, was generic, and saved her liver, to Lipitor all the time, which is not nearly as effective, destroys the liver, and costs a lot more. Every time we went for a refill, Lipitor was waiting for her and every time I had to fight the doctor to re-prescribe Simvastatin. Shame on that doctor!

In conclusion: keep your eyes and ears open! Do not let your doctor change your medications without good explanation and reason and without getting your consent! They must get your consent for every drug they give you. Changes behind your back indicate some kind of ugly monster you do not want to get involved with. As for the Big Pharma, the only way to get rid of them is by simply not getting sick. Do the best to your body to keep it fit and healthy and then who cares what they do?

Questions? Contact me.



About Angela A Stanton, Ph.D.

Angela A Stanton, PhD, is a Neuroeconomist focusing on chronic pain, electrolyte homeostasis, and genetics. She lives in Southern California. Her current research is focused on migraine cause, prevention and treatment without the use of medicines. As a forever migraineur from childhood, her discovery was helped by experimenting on herself. She found the cause of migraine to be at the ionic level, associated with disruption of the electrolyte homeostasis, resulting from genetic variations of all voltage gated channels that modulate electrolytes and voltage in the brain, insulin and glucose transporters, and several other related variants, such as the MTHFR variants of the B vitamin methylation process and many others. Migraineurs are glucose sensitive and should avoid eating carbs as much as possible. As a result of the success of the first edition of her book and new research and findings after treating over 4000 migraineurs world wide, all ages and both genders, she is now finishing the 2nd edition. The 2nd edition is the “holy grail” of migraines, incorporating all there is to know and also hypotheses. It includes an academic research section with suggestions for further research. The book is full of citations to authenticate the statements she makes to be followed up by those interested and to spark further research interest. It is a "Complete Guide". Due out in the summer of 2017. Dr. Stanton received her BSc at UCLA in Mathematics, MBA at UCR, MS in Management Science and Engineering at Stanford University, PhD in NeuroEconomics at Claremont Graduate University, and fMRI certification at Harvard University Medical School at the Martinos Center for Neuroimaging for experimenting with neurotransmitters on human volunteers. For relaxation Dr. Stanton paints and photographs. Follow her on Twitter at: @MigraineBook
This entry was posted in Interesting reading, Must Read, This & That, Thoughts and tagged , , , , , , , , , , , , , , , , , , , , , , , , . Bookmark the permalink.

5 Responses to Medication: Brand Name then Brand Name and then Brand Name again!

  1. Roald Michel says:

    “…….they create another version of the same drug with modifying something……..” And that was shocking to you? Hmmmm, old news to me though. Or was it low voltage?

    As for the rest of their tricks? Common practice for many companies. Belongs to the competition principle and making a profit philosophy. Nothing new there either.

    Liked by 1 person

I would love to see your thoughts!

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s